Skip to main content
An official website of the United States government

Funded Prevention Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Johnson, Jeremy James

University Of Illinois At Chicago
United States

Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer 5R37CA227101-07 Amit Kumar, Ph.D.
Kassie, Fekadu

University Of Minnesota
United States

Targeting tumor cell mitochondria for the prevention and treatment of lung cancer 5R01CA285608-02 John Clifford, Ph.D.
Khan, Seema Ahsan

Northwestern University At Chicago
United States

Northwestern Cancer Prevention Consortium 2UG1CA242643-07 Donald Johnsey
Kim, Hyung L

Cedars-Sinai Medical Center
United States

Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer 5R01CA280060-03 Howard L. Parnes, M.D.
Klopp, Ann

University Of Tx Md Anderson Can Ctr
United States

Defining a globally accessible and pragmatic predictive signature (GAPPS) for locally advanced cervical cancer 1R01CA301124-01 Goli Samimi, Ph.D., M.P.H.
Kong, Mei

University Of California-Irvine
United States

Using dietary glutamine supplementation for melanoma prevention and targeted therapy 5R01CA244360-05 Gabriela Riscuta, M.D., CNS
Kresty, Laura A

University Of Michigan At Ann Arbor
United States

Developing Natural Products to Target IL-8 Signaling and Intercept Progression of Barrett’s Esophagus to Esophageal Adenocarcinoma 1UG3CA299397-01 Altaf Mohammed, Ph.D.
Kumar, Nagi B.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Phase II Clinical trial of GTC in Men on Active Surveillance 5R01CA235032-06 Howard L. Parnes, M.D.
Langel, Stephanie N.

Case Western Reserve University
United States

Antibody bound bacteria during HPV infection and cervical dysplasia 3R21CA289927-02S1 Goli Samimi, Ph.D., M.P.H.
Leal, Ana Sofia Mendes

Indiana University Indianapolis
United States

Nrf2, immune cells and lung cancer 7R01CA226690-06 Marjorie Perloff, M.D.
Leslie, Kimberly K.

University Of New Mexico Health Scis Ctr
United States

Advancing Hormone Therapy for Endometrial Cancer 1P01CA278735-01A1 Goli Samimi, Ph.D., M.P.H.
Li, Bing

University Of Iowa
United States

E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function 5R01CA180986-11 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Li, Yong

Baylor College Of Medicine
United States

Cancer Prevention-Interception Against MGUS Progression 5U54CA272691-03 Anda Vlad, M.D., Ph.D.
Li, Chi

University Of Louisville
United States

A lung cancer vaccine based on exosomes of induced pluripotent stem cells 1R21CA280453-01 John Clifford, Ph.D.
Lu, Junxuan

Pennsylvania State Univ Hershey Med Ctr
United States

Early clinial trials for Angelica herbal supplements for prostate cancer interception 4R01CA260901-04 Gabriela Riscuta, M.D., CNS